Projektbeschreibung
Finanzierung des CEPI-Impfstoffs gegen COVID-19
Die COVID-19-Pandemie gefährdet Milliarden von Menschenleben und hat schwere Folgen für die globale Wirtschaft. Viele wollen daher möglichst schnell einen Impfstoff gegen diese Krankheit entwickeln. Angesichts der Millionen verzeichneten Todesfälle weltweit ist auch jede Bemühung um die Entwicklung eines Impfstoffs unentbehrlich. Das EU-finanzierte Projekt COVID-19 VACCINES will daher eine Kofinanzierung von der Europäischen Kommission gewinnen, um die Impfstoffentwicklung der „Coalition for Epidemic Preparedness Innovations“ (CEPI) zu unterstützen. Diese ist auf der Suche nach Programmen für Forschung und Entwicklung von Impfstoffen, die so vielen Menschen wie möglich zugänglich sein sollen.
Ziel
Funding of research and innovation programmes for the development of novel SARS-CoV-2 vaccine against COVID-19 disease
The overall objective is to leverage co-funding from the European Commission to support CEPI’s COVID-19 vaccine programme development efforts. The COVID-19 outbreak has in a short timeframe grown to a global pandemic of historic proportions, with detrimental humanitarian and economic consequences. All evidence now suggests that eradication of COVID-19 is not feasible and that we face a global public health crisis which is unprecedented in modern times. Investing in vaccine development now is an investment in the future health for all in our societies and a return to social and economic development – both in Europe and in the rest of the globe.
CEPI is seeking to support scientifically excellent research and development vaccine development programmes of a nature that will allow the broadest global access of the vaccines that are ultimately developed both within the current pandemic crisis and beyond. This will help curb the current ongoing outbreak, that is resulting in human suffering and a grave global economic crisis. CEPI was set up to respond to the crisis, where our vision is a world in which epidemics are no longer a threat to humanity. Our strategic objectives are further aligned with the sustainable
development goals 3, 8 and 17. Of particular importance to CEPI’s work is to try and ensure that low- and low-middle income countries (LICs and LMICs, respectively) will have access to the vaccines to protect their most vulnerable population, as soon as a vaccine is made available and irrespective of their ability to pay. As the current pandemic has shown, viruses respect no borders. To successfully curb the COVID-19 pandemic and beyond, we must ensure that all countries have the necessary tools to control the outbreak domestically. No-one is safe until everyone is safe.
Wissenschaftliches Gebiet
- natural sciencesbiological sciencesmicrobiologyvirology
- medical and health scienceshealth sciencespublic healthepidemiologypandemics
- medical and health scienceshealth sciencesinfectious diseasesRNA virusescoronaviruses
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsvaccines
Schlüsselbegriffe
Programm/Programme
Thema/Themen
Aufforderung zur Vorschlagseinreichung
Andere Projekte für diesen Aufruf anzeigenUnterauftrag
H2020-SGA-SC1-CEPI-2020
Finanzierungsplan
CSA - Coordination and support actionKoordinator
0277 OSLO
Norwegen